Keppra (Levetiracetam) Study in Dogs with Canine Epilepsy
Description: Clinical trial evaluating the safety and efficacy of levetiracetam in epileptic dogs whose seizures are poorly controlled with standard anticonvulsant medications
Eligibility: Dogs must be on therapeutic levels of standard anticonvulsants (phenobarbital and/or potassium bromide) and continue to seizure 4 or more times each month
Financial incentive: Cost of all evaluations, laboratory work and study medication are provided free-of-charge
Contact: For more information email: animalepilepsy@ncsu.edu or call 919.513.6812





WRAL.com welcomes your comments on this story. All comments are moderated prior to publication based on our posting guidelines. Please review them prior to posting and if your message is not approved.
This story is closed for comments. Comments on WRAL.com news stories are accepted and moderated between the hours of 8 a.m. and 8 p.m. Monday through Friday.